Angela Spivey is quoted on 2023’s top regulation trends in the food industry and offers insights for companies looking to prepare, and Sam Jockel weighs in on his and Ben Wolf’s predictions.
In the News
January-February 2023
Quality Assurance Magazine | Three Food Industry Trend Predictions for the Year Ahead
Related News & Insights
-
Advisories May 13, 2025FDA: Compliance & Enforcement / FDA: Drug & Device Advisory | New Executive Order Focuses on Reshoring and Increased Foreign Inspections of Pharmaceutical Manufacturing FacilitiesOur FDA Team examines the new Executive Order for promoting domestic production of critical medicines and the Food and Drug Administration’s announcement of expanding the use of surprise inspections at foreign manufacturing facilities.
-
Speaking Engagement April 30, 2025Diagnosing the Disease: Regulation of LDTs and IVDsBen Wolf will present during this virtual program hosted by the Practicing Law Institute (PLI).
-
Advisories April 15, 2025FDA/Food, Drug & Device Advisory | Addressing Data Integrity Challenges in Medical Device SubmissionsThe Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, valid data for medical device premarket submissions. Our FDA/Food, Drug & Device Team shares best practices for applicants that engage third-party laboratories to generate data for their FDA submissions.
-
In the News April 13, 2025HBW Insights | Momentum of Questions About Self-GRAS Meets Wall of Exemption from ‘Rigorous Review’Sam Jockel is quoted on the move to eliminate the “generally recognized as safe” pathway for food ingredients.
-
In the News April 8, 2025Mobi Health News | Q&A: What FDA Layoffs Mean for MedTech ApprovalsBen Wolf is featured on how layoffs at the Food and Drug Administration could impact medical-device approvals.
-
In the News April 1, 2025Law360 | FDA Cuts Prompt Biotech Players to Rethink Deal StrategiesBen Wolf is quoted on the Food & Drug Administration workforce cuts’ impact on the medical technology sector.
-
Speaking Engagement March 26–28, 202512th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care ProductsJoin Cathy Burgess for a pre-conference workshop on March 26 as she discusses “Beauty and the Law 101: Introduction to Cosmetics and Personal Care Products Law and Regulations.”
-
Speaking Engagement March 19–20, 202543rd Annual FDA Boot CampCathy Burgess will speak on the panel “cGMPs: Discovering the Unique Role of Current Good Manufacturing Practices (cGMPs) in the Post Approval Process” at this two-day conference hosted by the American Conference Institute.
-
Advisories March 12, 2025FDA/Food, Drug & Device / Health Care Advisory | FDA Resolves Semaglutide Shortage: Next Steps for Community Pharmacies, Telehealth Companies, and Other ProvidersNow that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and Health Care Groups have developed an initial checklist for providers to consider during the FDA’s enforcement discretion period.
-
In the News February 18, 2025ABA Journal | After SCOTUS Arguments on Sweet Vape Flavors, Some Lawyers Hope Opinion Brings More FDA ClarityMarc Scheineson is quoted on a Supreme Court case involving the authority of the Food and Drug Administration to regulate e-cigarettes.
Media Contact